Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (211-220 of 368) with videos related to

Pageof 37
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 23, 2023
Health-related quality of life among people who inject drugs in AustraliaQinglu Cheng, Sahar Bajis, Evan Cunningham, et al.
The International Journal on Drug Policy|April 8, 2026
A peer-delivered mobile model to enhance access to hepatitis C point-of-care testing and treatment: The Peers on Wheels studyM J Stowe, Rodd Hinton, Briallen Lloyd, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infectionMaryam Alavi, Jason Grebely, Gail V Matthews, et al.
Hepatology (Baltimore, Md.)|October 26, 2019
Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral InfectionMarianne Martinello, Chloe Orkin, Graham Cooke, et al.
Open Forum Infectious Diseases|November 29, 2023
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot StudyAnna Conway, Annabelle Stevens, Carolyn Murray, et al.
Addiction (Abingdon, England)|October 17, 2020
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian citiesSuzanne Nielsen, Paul Sanfilippo, Vendula Belackova, et al.
Addiction (Abingdon, England)|October 10, 2015
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS StudyJason Grebely, Maryam Alavi, Michelle Micallef, et al.
The Journal of Molecular Diagnostics : JMD|July 1, 2018
Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot SamplesFrançois M J Lamoury, Behzad Hajarizadeh, Angelica Soker, et al.
The International Journal on Drug Policy|March 2, 2023
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot StudyJason Grebely, Rosie Gilliver, Tony McNaughton, et al.
Addiction (Abingdon, England)|April 3, 2023
Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysisChrianna Bharat, Paige Webb, Zachary Wilkinson, et al.
Pageof 37

Showing results (211-220 of 368) with videos related to

Sort By:
Pageof 37
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 23, 2023
Health-related quality of life among people who inject drugs in AustraliaQinglu Cheng, Sahar Bajis, Evan Cunningham, et al.
The International Journal on Drug Policy|April 8, 2026
A peer-delivered mobile model to enhance access to hepatitis C point-of-care testing and treatment: The Peers on Wheels studyM J Stowe, Rodd Hinton, Briallen Lloyd, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infectionMaryam Alavi, Jason Grebely, Gail V Matthews, et al.
Hepatology (Baltimore, Md.)|October 26, 2019
Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral InfectionMarianne Martinello, Chloe Orkin, Graham Cooke, et al.
Open Forum Infectious Diseases|November 29, 2023
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot StudyAnna Conway, Annabelle Stevens, Carolyn Murray, et al.
Addiction (Abingdon, England)|October 17, 2020
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian citiesSuzanne Nielsen, Paul Sanfilippo, Vendula Belackova, et al.
Addiction (Abingdon, England)|October 10, 2015
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS StudyJason Grebely, Maryam Alavi, Michelle Micallef, et al.
The Journal of Molecular Diagnostics : JMD|July 1, 2018
Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot SamplesFrançois M J Lamoury, Behzad Hajarizadeh, Angelica Soker, et al.
The International Journal on Drug Policy|March 2, 2023
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot StudyJason Grebely, Rosie Gilliver, Tony McNaughton, et al.
Addiction (Abingdon, England)|April 3, 2023
Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysisChrianna Bharat, Paige Webb, Zachary Wilkinson, et al.
Pageof 37